BMJ2d
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis
1 Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands 2 Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands 3 Department of Molecular ...
BMJ2d
Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial
Objective To investigate whether an intensive early rheumatoid arthritis (RA) treat-to-target (T2T) strategy could be improved through the use of musculoskeletal ultrasound (MSUS) assessment of ...
BMJ2d
AB0156 NMR-BASED MUSCLE METABOLOMICS IN INFLAMMATORY MYOSITIS- UNDERSTANDING CHANGES IN SERUM AS A REFLECTION OF THE MUSCLE
Background: We have previously found promise in NMR as a tool to distinguish sera of active from inactive inflammatory myositis (IIM)1. To understand the changes previously found in sera and urine we ...
BMJ2d
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
Objective: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA). Methods: Patients with PsA who completed a 24-week, double-blind study ...
BMJ2d
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases
A substantial and persuasive body of data now exists that supports the view that integrin alpha V beta 3 plays a critical part in activated macrophage dependent inflammation, osteoclast development, ...
BMJ2d
Smoking and musculoskeletal disorders: findings from a British national survey
MRC Environmental Epidemiology Unit, Community Clinical Sciences, University of Southampton, UK Correspondence to: Dr K T Palmer, MRC Environmental Epidemiology Unit, Southampton General Hospital, ...
BMJ2d
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries
Objective: To conduct a cross-sectional review of non-selected consecutive outpatients with rheumatoid arthritis (RA) as part of standard clinical care in 15 countries for an overview of the ...
BMJ2d
Prognosis and management of polymyalgia rheumatica.
Polymyalgia rheumatica (PMR) is considered to be a benign disease by some, while others think it is a more serious illness which required similar treatment to giant cell arteritis (GCA). The progress ...
BMJ3d
It is time to rethink juvenile idiopathic arthritis classification and nomenclature
Correspondence to Alberto Martini, University of Genoa, Pediatria II, Istituto G Gaslini, Largo Gaslini 5, Genova 16147, Italy; albertomartini{at}ospedale-gaslini.ge.it Juvenile idiopathic arthritis ...
BMJ3d
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
41 St. Joseph's Health Care London and University of Western Ontario, London, Ontario, Canada Objective The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis ...
BMJ4d
Erosive hand osteoarthritis: its prevalence and clinical impact in the general population and symptomatic hand osteoarthritis
1 Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands 2 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 3 Department of ...
BMJ4d
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series
Correspondence to Dr Adi Diab, Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center FC3004, 1515 Holcombe Blvd Houston, Texas; adiab{at}mdanderson.org Background Immune ...